LIZETTE ALVARADO: Open Payments
NPI 1083388185 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 30 payments from 13 companies in 2025. Trend: 2023 $469 · 2024 $1,141 · 2025 $1,009
Food & beverage: $909Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $500 |
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| Astellas Pharma US Inc | 1 | $100 |
| Amgen Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Exact Sciences Corporation | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Intra-Sana Laboratories | 2 | $32 |
| REVANCE THERAPEUTICS, INC. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: BOTOX, REXULTI, CAPLYTA, Cologuard Collection Kit, FARXIGA, RELTONE 200 MG, OTEZLA, DAXXIFY.
Industry payments across LA — which companies pay providers there.
